Industry

Exhibition
Collapse/Expand
EEC2022ExhibitionPlan
Space # Company
101 Jazz Pharma
102 Angelini Pharma
103 LivaNova
201 UCB
301 Eisai
302 Desitin
303 Takeda
313 Neuro Event Labs
304 UNEEG medical
305 BIOCODEX
306 Nutricia
402 Brainlab
403 AIT (Austrian Institute of Technology)
405 vCreate
406 Micromed Group
407 John Libbey EUROTEXT
408 Ad-Tech Medical Instrument Corporation
409 Deep Breath Intelligence AG
410 Compumedics
501 Nihon Kohden
502 DIXI medical
601 ILAE YES
602 Persyst Development Corp.
604 Medtronic
605 Seer
701 PTC Therapeutics
702 Stoke Therapeutics
703 Ripple
801 Epilog
802 BESA
803 Neuroventis
805 Natus
806 NightWatch
Not-for-Profit Tables Anita Kaufmann Foundation
Dravet Syndrome European Foundation
EpiCare
Swiss League Against Epilepsy

 

Sponsors
Collapse/Expand
Major Partner   Partners    
Jazz_Logo
Jazz Pharma
 
Angelini_Logo
Angelini Pharma
 
UCB_Logo
UCB

 

Supporters            
Takeda_Logo
Takeda
 
MMC_Logo
Miller Medical Communications
 
Eisai_Logo
Eisai 
 
LivaNova_Logo
LivaNova

 

Contributors            
PTC_Logo
PTC Therapeutics
 
Epilog_Logo
Epilog
 
Nutricia_Logo
Nutricia
   

 

Patrons                
UNEEG_Logo
UNEEG medical
 
Orion_Logo
Orion Pharma
 
Persyst_Logo
Persyst Development Corporation
 
BESA_Logo
BESA
 
Xenon_Logo
Xenon Pharma
                 
Medtronic_Logo
Medtronic
 
Desitin_Logo
Desitin
 
Bioodex_Logo
BIOCODEX
 
Seer_Logo
Seer
 
vCreate_Logo
vCreate
                 
Micromed_Logo
Micromed Group
 
AD-Tech_Logo
Ad-Tech Medical Instrument Corporation
 
Ripple_Logo
Ripple
 
NK_Logo
Nihon Kohden
 
Brainlab_Logo
Brainlab
                 
AIT_Logo
AIT (Austrian Institute of Technology)
 
DIXI_Logo
DIXI medical
 
Stoke_Logo
Stoke Therapeutics
 
NightWatch_Logo
NightWatch
 
Compumedics_Logo
Compumedics

 

Satellite Symposia
Time & Date 16:30-18:00, Saturday, 9 July 2022
Location Room W
Chair Lieven Lagae (Belgium)
Presentation 1 Annamaria Vezzani (Italy): Why do some patients become pharmacoresistant? What we know and open questions.
Presentation 2 Fabrice Batolomei (France): What can functional connectivity tell us about effects of VNS?
Presentation 3 Lieven Lagae (Belgium): Beyond seizure progression: mechanisms of cognitive and behavioral impairment in epileptic encephalopathies.
Time & Date 16:30-18:00, Saturday, 9 July 2022
Location Room V
Speakers Renzo Guerrini (Italy) & Nicola Specchio (Italy)
Time & Date 08:00-09:30, Sunday, 10 July 2022
Location Room W
Chair Caroline Neuray (Belgium)
Presentation 1 Margitta Seeck (Switzerland): Role of ESI in adults
Presentation 2 Nick Kane (United Kingdom): Use of ESI in paediatric population
Presentation 3 Vadym Gnakovsky (Germany): The added value of ESI
Presentation 4 Pieter van Mierlo (Belgium): Case-based workshop
Time & Date 16:45-18:15, Sunday, 10 July 2022
Location Room W
Chair Margitta Seeck (Switzerland)
Presentation 1 Margitta Seeck (Switzerland): Introduction & clinical cases
Presentation 2 Adam Strzelczyk (Germany): Management of elderly patients with epilepsy
Presentation 3 Simona Lattanzi (Italy): Pharmacological treatment of epilepsy in elderly: clinical insights
Time & Date 08:00-09:30, Monday, 11 July 2022
Location Room W
Chair Francesco Porta (Italy)
Presentation 1 Bruria Ben-Zeev (Israel): Identifying AADC deficiency – an underdiagnosed and underreported neurometabolic disorder
Presentation 2 Francesco Porta (Italy): Therapeutic landscape for AADC deficiency: Key clinical data and patient outcomes
Presentation 3 Richard Poulin (USA): The AADC deficiency patient journey: A caregiver’s perspective
Time & Date 13:45-15:00, Monday, 11 July 2022
Location Room W
Chair John Paul Leach (United Kingdom)
Presentation 1 Ley Sander (United Kingdom): Towards seizure freedom: getting the best of Antiseizure medications
Presentation 2 John Paul Leach (United Kingdom): An overview of the key clinical trial data for cenobamate
First Debate From clinical evidence to real world experience
Second Debate Where now for ASM Clinical Trials?
Panel Bettina Schmitz (Germany), Vicente Villanueva (Spain), Ley Sander (United Kingdom)

 MMC

Time & Date 13:45-15:00, Tuesday, 12 July 2022
Location Room W
Chair Rima Nabbout (France)
Presentation 1 Rima Nabbout (France): The Importance of Non-Seizure Outcomes in DEEs: An Overview
Presentation 2 Renzo Guerrini (Italy): Improving Non-Seizure Outcomes in DEEs with Targeted Therapies
Presentation 3 Jeffrey Noebels (USA): Effect of Targeted Therapies on SUDEP Mortality: An Update
Time & Date 16:45-18:15, Tuesday, 12 July 2022
Location Room W
Chair Bernhard Steinhoff (Germany)
Presentation 1 Eva Theochari (United Kingdom): Switching between monotherapies or adding another antiseizure medication? A case supporting rational polytherapy
Presentation 2 Angelo Labate (Italy): iCases, clinical experience of early add on adjunctive anti-seizure medication

#EEC2022 Begins in

263Days : 10Hours : 15Minutes : 33Seconds

Key Dates

Congress Begins

9 July, 2022

Subscribe to the ILAE Newsletter

To subscribe, please click on the button below.

Please send me information about ILAE activities and other
information of interest to the epilepsy community